Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas. (Q51365893)

4 April 2018

title

Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas. (English)

1 reference

4 April 2018

0 references

1 reference

Katerina K Naka

1

1 reference

4 April 2018

Katerina Papathanassiou

2

1 reference

4 April 2018

Aris Bechlioulis

3

1 reference

4 April 2018

Konstantinos Pappas

4

1 reference

4 April 2018

Nikolaos Kazakos

5

1 reference

4 April 2018

Chryssanthi Kanioglou

6

1 reference

4 April 2018

Aggeliki Kostoula

7

1 reference

4 April 2018

Patra Vezyraki

8

1 reference

4 April 2018

Demetrios Makriyiannis

9

1 reference

4 April 2018

Agathocles Tsatsoulis

10

1 reference

4 April 2018

Lampros K Michalis

11

1 reference

4 April 2018

language of work or name

English

0 references

publication date

2 November 2011

1 reference

4 April 2018

Diabetes and Vascular Disease Research

published in

1 reference

4 April 2018

volume

9

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

52-58

1 reference

4 April 2018

The evolving diabetes burden in the United States

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Improved endothelial function with metformin in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Flow-mediated dilation and cardiovascular event prediction: does nitric oxide matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Metformin therapy and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Metformin improves endothelial function in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164111424515

21 January 2018

Identifiers

DOI

10.1177/1479164111424515

1 reference

4 April 2018

PubMed ID

22049096

1 reference

4 April 2018